Literature DB >> 21212063

Relationship between menopausal symptoms and risk of postmenopausal breast cancer.

Yi Huang1, Kathleen E Malone, Kara L Cushing-Haugen, Janet R Daling, Christopher I Li.   

Abstract

BACKGROUND: Prior studies indicate that women with menopausal symptoms have lower estrogen levels because they go through menopause as compared with women who do not experience them. Given the central role of hormones in the etiology of breast cancer, a link between menopausal symptoms and breast cancer is plausible. However, no prior studies have evaluated the association between menopausal symptoms and breast cancer risk.
METHODS: Utilizing data from a population-based case-control study we examined associations between menopausal symptoms and risks of different histologic types of breast cancer among postmenopausal women. We calculated multivariate adjusted odds ratios (OR) using polytomous logistic regression and evaluated several potential effect modifiers.
RESULTS: Women who ever experienced menopausal symptoms had lower risks of invasive ductal carcinoma [(IDC) OR = 0.5; 95% CI: 0.3-0.7], invasive lobular carcinoma (ILC, OR = 0.5; 95% CI: 0.3-0.8), and invasive ductal-lobular carcinoma (IDLC, OR = 0.7; 95% CI: 0.4-1.2), and these reductions in risk were independent of recency and timing of hormone therapy use, age at menopause, and body mass index. Increasing intensity of hot flushes among women who ever experienced hot flushes was also associated with decreasing risks of all three breast cancer subtypes (P values for trend all ≤ 0.017).
CONCLUSION: This is the first study to report that women who ever experienced menopausal symptoms have a substantially reduced risk of breast cancer, and that severity of hot flushes is also inversely associated with risk. IMPACT: If confirmed, these findings could enhance our understanding of breast cancer etiology and factors potentially relevant to prevention. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21212063      PMCID: PMC3037725          DOI: 10.1158/1055-9965.EPI-10-0998

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  Cancer statistics, 2000.

Authors:  R T Greenlee; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  2000 Jan-Feb       Impact factor: 508.702

2.  The true clincal features of postmenopause and oöphorectomy, and their response to oestrogen therapy.

Authors:  W H Utian
Journal:  S Afr Med J       Date:  1972-06-03

3.  An investigation of the age at menopause.

Authors:  S McKinlay; M Jefferys; B Thompson
Journal:  J Biosoc Sci       Date:  1972-04

Review 4.  Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.

Authors:  M C Pike; D V Spicer; L Dahmoush; M F Press
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

5.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Authors:  T Key; P Appleby; I Barnes; G Reeves
Journal:  J Natl Cancer Inst       Date:  2002-04-17       Impact factor: 13.506

6.  Longitudinal study of hormone levels and depression among women transitioning through menopause.

Authors:  N E Avis; S Crawford; R Stellato; C Longcope
Journal:  Climacteric       Date:  2001-09       Impact factor: 3.005

7.  Oestrogen therapy and the menopausal syndrome.

Authors:  S Campbell; M Whitehead
Journal:  Clin Obstet Gynaecol       Date:  1977-04

Review 8.  What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause.

Authors:  Winfried G Rossmanith; Wiebke Ruebberdt
Journal:  Gynecol Endocrinol       Date:  2009-05       Impact factor: 2.260

Review 9.  Endogenous hormones and breast cancer risk.

Authors:  L Bernstein; R K Ross
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

10.  Estrogen levels in postmenopausal women with hot flashes.

Authors:  Y Erlik; D R Meldrum; H L Judd
Journal:  Obstet Gynecol       Date:  1982-04       Impact factor: 7.661

View more
  8 in total

1.  Menopausal symptoms and the risk of young-onset breast cancer.

Authors:  Chunyuan Fei; Lisa A DeRoo; Dale P Sandler; Clarice R Weinberg
Journal:  Eur J Cancer       Date:  2012-09-27       Impact factor: 9.162

2.  Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women's Health Across the Nation.

Authors:  Vicki Hart; Susan R Sturgeon; Nicholas Reich; Lynnette Leidy Sievert; Sybil L Crawford; Ellen B Gold; Nancy E Avis; Katherine W Reeves
Journal:  Cancer Causes Control       Date:  2016-09-28       Impact factor: 2.506

3.  Understanding the Association of Type 2 Diabetes Mellitus in Breast Cancer Among African American and European American Populations in South Carolina.

Authors:  Marsha E Samson; Swann Arp Adams; Olubunmi Orekoya; James R Hebert
Journal:  J Racial Ethn Health Disparities       Date:  2015-10-20

4.  Relationship between menopause and health-related quality of life in middle-aged Chinese women: a cross-sectional study.

Authors:  Kuo Liu; Liu He; Xun Tang; Jinwei Wang; Na Li; Yiqun Wu; Roger Marshall; Jingrong Li; Zongxin Zhang; Jianjiang Liu; Haitao Xu; Liping Yu; Yonghua Hu
Journal:  BMC Womens Health       Date:  2014-01-10       Impact factor: 2.809

5.  Temporal trend, clinicopathologic and sociodemographic characterization of age at diagnosis of breast cancer among US women diagnosed from 1990 to 2009.

Authors:  Gabriel Escarela; Luis Carlos Pérez-Ruiz; Gabriel Núñez-Antonio
Journal:  Springerplus       Date:  2014-10-23

6.  Long-Term Cause-Specific Mortality After Surgery for Women With Breast Cancer: A 20-Year Follow-Up Study From Surveillance, Epidemiology, and End Results Cancer Registries.

Authors:  Gabriel Escarela; Alan Jiménez-Balandra; Gabriel Núñez-Antonio; Antonio Gordillo-Moscoso
Journal:  Breast Cancer (Auckl)       Date:  2017-06-01

7.  Can postfertile life stages evolve as an anticancer mechanism?

Authors:  Frédéric Thomas; Mathieu Giraudeau; François Renaud; Beata Ujvari; Benjamin Roche; Pascal Pujol; Michel Raymond; Jean-François Lemaitre; Alexandra Alvergne
Journal:  PLoS Biol       Date:  2019-12-05       Impact factor: 8.029

8.  Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial.

Authors:  Michael J Hale; Anthony Howell; Mitch Dowsett; Jack Cuzick; Ivana Sestak
Journal:  Breast       Date:  2020-10-31       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.